Drug
Nadroparin clinical trials
Also written Fraxiparin and Fraxiparine.
- studies test it
- 20
- open now
- 1
- in phase 3
- 6
- first study started
- 2002
Keep track of what changes. Save the Nadroparin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Other names
Combined with it in one product
Studies by the year they started
19 studies that test it; most in 2013 (4)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 4 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 2
- Phase 3
- 6
- Phase 4
- 10
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 18
Shanghai Zhongshan Hospital (3) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Clinique Saint Pierre Ottignies (1) · Qilu Hospital of Shandong University (1) · Martini Hospital Groningen (1) · University Hospital, Geneva (1) · GlaxoSmithKline (1) · Italfarmaco (1)
Often tested with
Tested in the same studies.
Warfarin (4) · Fondaparinux (2) · Enoxaparin (1) · Dalteparin (1) · Tinzaparin (1) · Dabigatran (1) · Rivaroxaban (1) · Trisodium citrate (1)
Studies
Open first, then newest update. How each study uses Nadroparin is read from its arms, and is right about nine times in ten.
Testing it · 20
- Improving Outcome in Subarachnoid Hemorrhage wIth NadroparineRecruitingPhase 2Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT04507178Written as Nadroparin Injectable Product
- Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in PregnancyCompletedPhase 4Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT01828697Written as Low dose nadroparin
- Intravenous Versus Subcutaneous Administration of Low Molecular Weight Heparin for Thromboprophylaxis in Critically Ill PatientsCompletedPhase 4Clinique Saint Pierre OttigniesNCT04982055Written as Nadroparin (intravenous Infusion)
- Efficacy and Safety of Anticoagulant Therapy in Portal Vein ThrombosisCompletedPhase 4Qilu Hospital of Shandong UniversityNCT04173429Written as Nadroparin calcium, warfarin
- Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty SurgeryCompletedPhase 3Martini Hospital GroningenNCT01431456Written as Nadroparin
- Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)CompletedPhase 3University Hospital, GenevaNCT00421538Written as nadroparine calcium
- Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate CancerCompletedPhase 3GlaxoSmithKlineNCT00312013Written as Nadroparin
- Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver CirrhosisWithdrawnNot applicableAir Force Military Medical University, ChinaNCT02526303Written as Nadroparin Calcium and Warfarin
- LMWH Infusion as Anticoagulation for Home HDStatus unknownPhase 4Alice Ho Miu Ling Nethersole HospitalNCT02957877Written as Nadroparin
- The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCTStatus unknownPhase 4Shanghai Zhongshan HospitalNCT02630095Written as Nadroparin Calcium and Warfarin
- The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein ThrombosisStatus unknownPhase 4Shanghai Zhongshan HospitalNCT02398357Written as Nadroparin Calcium and Warfarin
- Prophylaxis of Venous Thromboembolism After Bariatric SurgeryStatus unknownPhase 4Rijnstate HospitalNCT02295150Written as Nadroparin
- The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic SurgeryCompletedNot applicableShanghai Zhongshan HospitalNCT01267305Written as Nadroparin Calcium
- Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic StrokeStatus unknownPhase 4University Hospital, MartinNCT01862978Written as Nadroparin
- Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot FracturesStatus unknownPhase 2/3Red Cross Hospital BeverwijkNCT00881088Written as Nadroparin
- Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)CompletedPhase 3ItalfarmacoNCT00951574Written as Nadroparin calcium
- Heparin for Pregnant Women With ThrombophiliaStatus unknownPhase 3Medical University of ViennaNCT01019655Written as Nadroparin calcium
- Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous HemofiltrationCompletedPhase 4Onze Lieve Vrouwe GasthuisNCT00286273Written as nadroparin
- Nadroparin for the Initial Treatment of Pulmonary ThromboembolismCompletedPhase 4Beijing Chao Yang HospitalNCT00796692Written as Nadroparin
- OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in HemodialysisStatus unknownNot applicableIRCCS Azienda Ospedaliero-Universitaria di BolognaNCT00669721Written as law molecular weigth heparin
Given in every arm · 1 — Nadroparin is usual care beside what is tested
As the comparator · 5 — what is tested is compared with Nadroparin
- Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava FiltersRecruitingPhase 3Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT04066764Written as Nadroparin
- Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS StudyRecruitingPhase 3Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT04067505Written as Nadroparin
- Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVTNot yet recruitingNot applicableShanghai Zhongshan HospitalNCT06319131Written as Nadroparin
- A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing SurgeryCompletedPhase 3GlaxoSmithKlineNCT00843492Written as Nadroparin
- Prophylaxis of Venous Thromboembolism in Advanced Lung CancerStatus unknownPhase 3Shengqing LiNCT01980849Written as Nadroparin: short-term
Codes
What other systems call Nadroparin · ClinicalTrials.gg INT008612
- MeSH (NLM) D017762NadroparinConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) 1K5KDI46KZNADROPARINConfirmed FDA, Wikidata
- RxNorm 67031One source FDA
- Wikidata Q20817257nadroparinConfirmed FDA, Wikidata
- NCI Thesaurus C200713NadroparinOne source FDA
- DrugBank DB08813One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017762 | Nadroparin | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | 1K5KDI46KZ | NADROPARIN | Confirmed FDA, Wikidata |
| RxNorm | 67031 | — | One source FDA |
| Wikidata | Q20817257 | nadroparin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C200713 | Nadroparin | One source FDA |
| DrugBank | DB08813 | — | One source Wikidata |
Also registered as nadroparin calcium (UNII LIA7Z4002P).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.